高级搜索
甘氨双唑钠对鼻咽癌放射治疗的增敏作用[J]. 肿瘤防治研究, 2006, 33(03): 200-201. DOI: 10.3971/j.issn.1000-8578.426
引用本文: 甘氨双唑钠对鼻咽癌放射治疗的增敏作用[J]. 肿瘤防治研究, 2006, 33(03): 200-201. DOI: 10.3971/j.issn.1000-8578.426
Radiosensitivity on Nasopharyngeal Carcinoma by CMNa[J]. Cancer Research on Prevention and Treatment, 2006, 33(03): 200-201. DOI: 10.3971/j.issn.1000-8578.426
Citation: Radiosensitivity on Nasopharyngeal Carcinoma by CMNa[J]. Cancer Research on Prevention and Treatment, 2006, 33(03): 200-201. DOI: 10.3971/j.issn.1000-8578.426

甘氨双唑钠对鼻咽癌放射治疗的增敏作用

Radiosensitivity on Nasopharyngeal Carcinoma by CMNa

  • 摘要: 目的探讨甘氨双唑钠(CMNa)配合放射治疗对局部晚期鼻咽癌的临床疗效和毒副反应。方法40例鼻咽癌患者随机分为两组,治疗组(放疗+CMNa)20例,对照组(单纯放疗)20例,两组患者临床资料相似,放疗方法相同,均用常规分割,原发灶和颈转移灶剂量7000~7400cGy/35~37f/7~7.5w。治疗组放疗同时使用CMNa每次800mg/m2,每周3次,从放疗开始连续使用至放疗结束。结果治疗组和对照组患者治疗结束时肿瘤原发灶的完全消退率(CR率)分别为95.0%、85.0%,放疗剂量分别为4905.0cGy、5835.6cGy,颈转移灶CR率分别为89.5%、88.9%,放疗剂量分别为4500.0cGy、5342.8cGy,两组患者原发灶、颈转移灶达CR时的放射剂量不同,有统计学差异。毒副反应两组比较无统计学差异,未见神经系统毒性。结论CMNa合并放疗对鼻咽癌有增敏作用,可提高近期疗效,降低疗效达CR时所需的放射剂量,无明显毒副反应。

     

    Abstract: Objective To evaluate the radiosensitivity and toxicity of CMNa on local advanced nasopharyngeal carcinoma. Methods 40 patients with local advanced nasopharyngeal carcinoma were divided into two groups randomly: treatment group (n=20) and control group (n=20). The patients in treatment group were intravenous dripped CMNa 800mg/m 2 three times weekly during whole treatment period by nasopharyngeal carcinoma. Patients in control group were treated with radiotherapy alone. The method of radiotherapy in control...

     

/

返回文章
返回